Effects of aspartame on hsp70,bcl-2 and bax expression in immune organs of Wistar albino rats

作者:Arbind; Kumar; Choudhary; Rathinasamy; Sheela; Devi Department; of; Physiology; Dr.ALM.PG.Institute; of; Basic; Medical; Sciences; University; of; Madras; Taramani; Campus

摘要:Aspartame,a 'first generation sweetener',is widely used in a variety of foods,beverages,and medicine.The FDA has determined the acceptable daily intake(ADI) value of aspartame to be 50 mg/kg-day,while the JECFA(Joint FAO/WHO Expert Committee on Food Additives) has set this value at 40 mg/kg of body weight/day.Safety issues have been raised about aspartame due to its metabolites,specifically toxicity from methanol and/or its systemic metabolites formaldehyde and formic acid.The immune system is now recognized as a target organ for many xenobiotics,such as drugs and chemicals,which are able to trigger unwanted apoptosis or to alter the regulation of apoptosis.Our previous studies has shown that oral administration of aspartame[40 mg/(kg.day)]or its metabolites for 90 days increased oxidative stress in immune organs of Wistar albino rats.In this present study,we aimed to clarify whether aspartame consumption over a longer period(90-days) has any effect on the expression of hsp70,bcl-2 and bax at both mRNA transcript and protein expression levels in immune organs.We observed that oral administration of aspartame for 90 days did not cause any apparent DNA fragmentation in immune organs of aspartame treated animals;however,there was a significant increase in hsp70 expression,apart from significant alteration in bcl-2 and bax at both mRNA transcript and protein expression level in the immune organs of aspartame treated animals compared to controls.Hence,the results indicated that hsp70 levels increased in response to oxidative injury induced by aspartame metabolites;however,these metabolites did not induce apoptosis in the immune organs.Furthermore,detailed analyses are needed to elucidate the precise molecular mechanisms involved in these changes.

注:因版權(quán)方要求,不能公開全文,如需全文,請(qǐng)咨詢雜志社

南京醫(yī)科大學(xué)學(xué)報(bào)·自然科學(xué)版

北大期刊 下單

國(guó)際刊號(hào):1007-4368

國(guó)內(nèi)刊號(hào):32-1442/R

雜志詳情

服務(wù)介紹LITERATURE

正規(guī)發(fā)表流程 全程指導(dǎo)

多年專注期刊服務(wù),熟悉發(fā)表政策,投稿全程指導(dǎo)。因?yàn)閷W⑺詫I(yè)。

保障正刊 雙刊號(hào)

推薦期刊保障正刊,評(píng)職認(rèn)可,企業(yè)資質(zhì)合規(guī)可查。

用戶信息嚴(yán)格保密

誠(chéng)信服務(wù),簽訂協(xié)議,嚴(yán)格保密用戶信息,提供正規(guī)票據(jù)。

不成功可退款

如果發(fā)表不成功可退款或轉(zhuǎn)刊。資金受第三方支付寶監(jiān)管,安全放心。